4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-023718
President and CEO bought 13,000 shares at an average $5.85 ($75,990)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2019-09-13 | Purchase | +10,000 | $5.79 | $57,900 | 588,991 | D |
| Brady Todd C President and CEO | 2019-09-16 | Purchase | +3,000 | $6.03 | $18,090 | 591,991 | D |
| Open-market purchases · 13,000 sh · avg $5.85 · $75,990 | |||||||
Loading xslF345X03/doc4.xml…